Actavis on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for a generic version of Mallinckrodt's Exalgo (hydromorphone hydrochloride extended-release tablets 8 mg, 12 mg and 16 mg).
Actavis on Wednesday announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Labs, which is anticipated at mid-year.
Dr. Reddy's Labs has named Satish Reddy as chairman of the board. Reddy previously held the position of vice-chairman, managing director and COO. GV Prasad will continue to serve as CEO and provide leadership to the company in an executive capacity.
Mylan on Wednesday announced that it has launched olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths. The drug is the generic version of Zyprexa Zydis tablets from Eli Lilly and Co.
Retail sales rose ever so slightly in April, putting a damper on hopes of a sharp uptick in economic growth in the second quarter. According to the U.S. Commerce Department, retail sales — which include categories such as automobiles, gasoline stations and restaurants — rose 0.1% in April, following a revised 1.5% increase in March that ranked as the biggest since March 2010.
In a move that is squarely in line with CVS Caremark’s continued commitment to healthy living and its bold move to pull tobacco products from its stores, the pharmacy retailer has signed on as the national presenting sponsor of Lung Force, a national public heath initiative to fight lung cancer in women.
Interactions, a firm that organizes product demonstrations for retailers and brands, on Tuesday released its second Retail Perceptions trend report, “The Rise of Webrooming: A Changing Consumer Landscape.”